RSS Texas Bio News

  • Top of Texas 2016: Big Exits, Ride-Sharing Leaves Austin, & More December 30, 2016
    As 2016 comes to an end, let’s take a look at some of the more notable stories from Xconomy Texas over the past year. What follows is my highly subjective list of news that we covered in 2016. Notable exits and fundraises: —San Antonio cloud computing company Rackspace was bought by New York private equity […]
    Angela Shah
  • ‘Creepy Bird’ Anyone? Meet San Antonio’s Retro Video Game Developer December 30, 2016
    San Antonio—Video games are big business, and highly dynamic. From the Xbox to virtual reality, how players play has changed quite a bit since the Atari and the NES brought home gaming to the masses. One San Antonio video game developer is riding a wave of renewed interest in older gaming systems, starting a business […]
    David Holley
  • Despite Political Rhetoric, Staff Diversity Remains a Top Priority December 30, 2016
    I don’t think the election of Donald Trump as president does much to bolster those in tech working on creating a more inclusive and diverse industry, but I will continue to be a champion for it nonetheless. Specifically, I’ve ended 2016 by doubling our team at Localeur and introducing an Advisory Board, both of which […]
    Joah Spearman
  • Political Focus on Rust Belt Could Help Boost VC Investment December 29, 2016
    Much has been written in the tech industry as a result of the Presidential election. Many coastal VCs and entrepreneurs believe that Trump’s America-first, anti-immigration platform could put the brakes on the venture industry’s core globalization strategies. While this may be true, regardless of which candidate you supported, most would agree that with chaos and […]
    Blair Garrou
  • 6 Cybersecurity Predictions for 2017: Ransomware, Skills Gap & More December 28, 2016
    In 2016, we saw cyber attacks increasingly shift from external breaches of confidential data to internal disruption of data and services, as attackers used distributed denial of service (DDoS) or encryption to hold businesses hostage. Attackers continue to focus more on exploiting users than technology. Users are often unaware and uneducated about the potential risks, […]
    James Maude
  • East Coast Silicon Valley December 27, 2016
    “You never change things by fighting the existing reality. To change something, build a new model that makes the existing model obsolete.” – R. Buckminster Fuller Reinvention A few months ago I was talking to executives in charge of innovation at a large U.S. bank. “Our biggest problem is that we look at all this new […]
    Dan Deac
  • Immigration Restrictions, Lack of Healthcare Could Imperil Innovation December 27, 2016
    It’s hard to predict what effect the new administration will have, since we have very little information on any concrete policies they plan to enact. We do know a few things—namely, they are anti-Obamacare and anti-immigration. Decreasing the number of visas granted to highly skilled workers (a likely possibility given Steve Bannon’s comments on Silicon […]
    Shion Deysarkar
  • Ambiq Micro Lands $2,458,624 New Financing Round December 26, 2016
    Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b14cce5b-17e6-45ad-8174-a48eded4efe6 Date 12/26/2016 Company Name Ambiq Micro Mailing Address 11305 4 Points Drive West Lake Hills, TX 78726 USA Company Description A semiconductor company with a breakthrough patented technology, Subthreshold Power Optimized Technology (SPOT) that dramatically reduces the amount of power consumed by ICs. Website http://www.ambiqmicro.com Transaction Type Venture Equity Transaction Amount […]
    VentureDeal
  • Texas Roundup: “1st & Future,” “Pink Tank” Pitch Contests, & More December 23, 2016
    As we approach Santa’s annual visit—are your milk and cookies ready?—let’s get caught up with the latest innovation news from Xconomy Texas: —The National Football League has teamed up with the Texas Medical Center to sponsor the 1st & Future startup pitch competition Feb. 4, the day before the Super Bowl takes place in Houston. […]
    Angela Shah
  • Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More December 23, 2016
    You’ve probably seen the Internet memes. “When 2016 started, I looked like this. [Insert picture of young Leo DiCaprio.] Now I look like this. [Leo, with mountain beard, after mud-wrestling with a grizzly in The Revenant.]” In life science terms, let’s just say all our telomeres feel a lot shorter than 12 months ago. The […]
    Alex Lash

RSS National Bio News

  • Endo Provides Update On Opana ER July 6, 2017
    DUBLIN, July 6, 2017 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) continues to believe in the safety, efficacy, and favorable benefit-risk profile of Opana ER (oxymorphone hydrochloride extended release) when used as intended, and notes...
  • FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy July 3, 2017
    July 3, 2017 -- Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in...
  • Monthly News Roundup - June 2017 June 30, 2017
    New Fluoroquinolone Baxdela Approved for Certain Skin Infections Roughly 3 million patients are hospitalized each year in the U.S. with acute bacterial skin and skin structure infections (ABSSSIs), some of which may be difficult-to-treat and...
  • FDA Allows Marketing of Test to Aid in the Detection of Certain Leukemias and Lymphomas June 29, 2017
    June 29, 2017 -- The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas,...
  • FDA Unveils Plan to Eliminate Orphan Designation Backlog June 29, 2017
    June 29, 2017 -- Today, the U.S. Food and Drug Administration unveiled a strategic plan to eliminate the agency’s existing orphan designation request backlog and ensure continued timely response to all new requests for designation with firm...
  • FDA Tackles Drug Competition to Improve Patient Access June 27, 2017
    June 27, 2017 -- Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency published a list of off-patent,...
  • Sonar Products Ordered to Cease Operations, Stratus Pharmaceuticals Ordered to Cease Distributing Unapproved Drugs June 15, 2017
    June 15, 2017 -- Today, U.S. District Judge Kathleen M. Williams for the Southern District of Florida entered a consent decree of permanent injunction between the United States and Stratus Pharmaceuticals Inc. of Miami, Florida, Sonar Products Inc....
  • FDA Requests Removal of Opana ER for Risks Related to Abuse June 8, 2017
    June 8, 2017 -- Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is...
  • FDA Approves First Generic Truvada for HIV Infection and Pre-Exposure Prophylaxis (PrEP) June 8, 2017
    June 8, 2017 - The U.S. Food and Drug Administration has approved the first generic version of Truvada for the treatment of HIV-1, in combination with other antiretroviral agents, and for pre-exposure prophylaxis (PrEP) in combination with safer sex...
  • Monthly News Roundup - May 2017 May 30, 2017
    Actemra: First Drug Approved to Treat Giant Cell Arteritis Actemra (tocilizumab) from Hoffman La Roche has gained a new indication as the first drug approved to treat adults with giant cell arteritis, a specific type of vasculitis. Vasculitis is...
  • FDA Approves First Generic Strattera for the Treatment of ADHD May 30, 2017
    May 30, 2017 -- The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients. Apotex Inc., Teva Pharmaceuticals...
  • FDA Warns Americans About Risk of Inaccurate Results from Certain Lead Tests May 17, 2017
    May 17, 2017 -- The U.S. Food and Drug Administration and Centers for Disease Control and Prevention are warning Americans that certain lead tests manufactured by Magellan Diagnostics may provide inaccurate results for some children and adults in...

RSS Worldwide Bio News

  • 2017 Alzheimer Award Goes to Shi-Jiang Li for Developing CARE Index July 13, 2017
    This post was originally published on this site Prof. Shi-Jiang Li, PhD, is the recipient of the 2017 Alzheimer Award granted every year by the associate editors of the Journal of Alzheimer’s Disease (JAD). Li was singled out for his and his team’s outstanding work published in the journal about a new index called the […]
    admin
  • Ocrevus and Me, Part 2: Infusion Time and Side Effects July 13, 2017
    This post was originally published on this site Editor’s note: This column is second in a series. Read the first part here. Just you wait! How many times have we heard those words or said them to someone else? I find that now it’s my turn to wait. What I’m waiting for is six months […]
    admin
  • Phaware Podcast: Vic Tapson, MD, Part 2 July 13, 2017
    This post was originally published on this site This podcast series, created and produced by phaware, is being offered as a regular guest feature on Pulmonary Hypertension News to bring the voices and life experiences of PH patients, family members, caregivers, healthcare specialists, and others to our readers. You may listen to the podcast directly, or read it […]
    admin
  • Sarcoidosis Patients Incur High Medical Costs for Commercial Insurance Payers, Study Says July 13, 2017
    This post was originally published on this site A study assessing the healthcare resources and cost of sarcoidosis care to commercial insurance payers in the U.S. found that patients selected from a privately-insured administrative claims database had higher total healthcare costs and more lost work days on average in one year compared to control subjects […]
    admin
  • Cure SMA Launches National Newborn Screening Campaign July 13, 2017
    This post was originally published on this site The national nonprofit spinal muscular atrophy (SMA) support and advocacy organization Cure SMA has launched a grassroots campaign to have required newborn-screening for SMA in every state. The campaign was announced at the 2017 Annual SMA Conference held June 29-July 2 in Orlando, Florida. It was attended […]
    Charles Moore
  • Cure SMA Launches National Newborn Screening Campaign July 13, 2017
    This post was originally published on this site The national nonprofit spinal muscular atrophy (SMA) support and advocacy organization Cure SMA has launched a grassroots campaign to have required newborn-screening for SMA in every state. The campaign was announced at the 2017 Annual SMA Conference held June 29-July 2 in Orlando, Florida. It was attended […]
    Charles Moore
  • Innovate Seeks Orphan Drug Status for Pediatric Ulcerative Colitis Therapy Candidate INN-108 July 13, 2017
    This post was originally published on this site Innovate Biopharmaceuticals recently submitted an application to the U.S. Food and Drug Administration (FDA) seeking orphan drug designation for its potential pediatric ulcerative colitis therapy, INN-108. The FDA issues orphan drug designation to promising treatments for rare diseases affecting fewer than 200,000 people per year in the U.S. […]
    admin
  • Northwestern Researchers Find Immune Cells Link to Fibrosis, Reversing Previous Theories July 13, 2017
    This post was originally published on this site Certain immune cells contribute to the development of fibrosis, researchers at Chicago’s Northwestern Medicine discovered in a study that might overturn the view of lung fibrosis as a disease unaffected by immune processes. The report titled, “Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the […]
    Magdalena Kegel
  • People with Chorea Can Switch from Xenazine To Austedo Safely, Phase 3 Clinical Trial Shows July 13, 2017
    This post was originally published on this site Huntington’s patients who are taking Xenazine for the twitching condition known as chorea can switch without concern to the newly approved Austedo, according to Austedo’s maker, Teva Pharmaceutical Industries. A Phase 3 clinical trial showed that the switch was safe and that Austedo (deutetrabenazine) did a better job of controlling […]
    admin
  • Imaging Techniques Combo Helps Better Evaluate Bone Disease Risk in Gaucher Patients, Study Finds July 13, 2017
    This post was originally published on this site Researchers found that combining a new, noninvasive technique called trabecular bone score (TBS) with bone mineral density techniques helps to better identify Gaucher disease patients at increased risk for bone fractures. The study, “Skeletal involvement in type 1 Gaucher disease: Not just bone mineral density,” was published in […]
    admin